Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;97(1):25.
doi: 10.1186/s42506-022-00122-4.

Determinants of coronavirus disease 2019 vaccine acceptance, hesitancy, and barriers among healthcare workers in Ismailia, Egypt: a mixed methods study

Amani Waheed  1 , Noha M Abu Bakr Elsaid  2   3 , Mayada Ghweeba  1 , Nermine Elmaraghy  4 , Shimaa A Al-Touny  5 , Nader Nemr  6 , Rania M Kishk  4 , Hebatalla M Aly  1
Affiliations

Determinants of coronavirus disease 2019 vaccine acceptance, hesitancy, and barriers among healthcare workers in Ismailia, Egypt: a mixed methods study

Amani Waheed et al. J Egypt Public Health Assoc. .

Abstract

Background: Coronavirus disease 2019 vaccine acceptance among healthcare workers (HCWs) plays a fundamental role in combating the COVID-19 pandemic. Vaccination acceptance depends on perceptions of competence and motives of the providers, producers, health professionals, and policymakers. This study aimed to identify the frequency and determinants of COVID-19 vaccine uptake acceptance, hesitancy, and barriers among HCWs.

Methods: A total of 500 HCWs from 3 different hospital affiliations in Ismailia Governorate, Egypt, were included in this mixed methods study. The study was conducted between March and April 2021 through two phases. Phase 1 included a cross-sectional study using a self-administered questionnaire with inquiries about different determinants of vaccine acceptance, hesitancy, and barriers, which was completed either electronically in a Google form or a hard printed copy. Phase 2 included four focus group discussions to explore the determinants in depth.

Results: The mean age of participants was 33.9 ± 7.9 years, 70% were females, 51.2% were nurses, and 28.6% were physicians. Of the 500 HCWs, only 27.8% accepted taking the vaccine immediately, 49.2% refused, and 23% were hesitant. Vaccine safety was the highest associated factor with vaccine acceptance (odds ratio (OR) = 6.3, 95% confidence interval (CI) 3.132-12.619), followed by previous uptake of influenza vaccine (OR = 3.3, 95% CI 2.048-5.217) and vaccine effectiveness (OR = 2.6, 95% CI 1.282-5.262). The main barriers to vaccine acceptance were mistrust in governmental policies during the pandemic or in the healthcare facility they work in. Hesitancy was common among females and nurses and was attributed to three prominent factors, including safety concerns, negative stories, and personal knowledge.

Conclusions: The vaccine acceptance frequency among HCWs was considered low, as the majority either refused or was hesitant about taking the vaccine. Concerns about vaccine safety and effectiveness were significant determinants of vaccine acceptance. Factors related to trust were the main barriers to vaccine uptake. The health authority should establish a surveillance system for side effects of the COVID-19 vaccine and communicate this information between HCWs to decrease their worries about safety and increase vaccine uptake.

Keywords: Coronavirus disease 19 vaccination; Healthcare workers; Qualitative study; Vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
COVID-19 infection history among participating healthcare workers from Ismailia, Egypt in the 1st half of 2021 (n = 500)
Fig. 2
Fig. 2
Vaccine acceptance levels among the participating healthcare workers from Ismailia, Egypt in the 1st half of 2021 (n = 500)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol. 2021;74:168–184. doi: 10.1016/j.jhep.2020.09.031. - DOI - PMC - PubMed
    1. Fiorillo A, Gorwood P. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur Psychiatry. 2020;63:e32. doi: 10.1192/j.eurpsy.2020.35. - DOI - PMC - PubMed
    1. Hasnain M, Pasha MF, Ghani I. Combined measures to control the COVID-19 pandemic in Wuhan, Hubei, China: a narrative review. J Biosaf Biosecurity. 2020;2:51–57. doi: 10.1016/j.jobb.2020.10.001. - DOI - PMC - PubMed
    1. Sleator RD, Darby S, Giltinan A, Smith N. COVID-19: in the absence of vaccination - ‘mask the nation’. Future Microbiol. 2020;15:963–966. doi: 10.2217/fmb-2020-0112. - DOI - PMC - PubMed
    1. Worled Health Oranization. WHO Health Emergency Dashboard of COVID-19 2022. https://covid19.who.int/region/emro/country/eg

LinkOut - more resources